Heron Therapeutics (HRTX) Tax Rate (2014 - 2015)
Heron Therapeutics' (HRTX) quarterly Tax Rate came in at 363.99% in Q4 2015, down 36338.0% on a YoY basis from N/an in Q4 2014, and down 59712.26% quarter-over-quarter from 0.61% in Q4 2014.
Powered by 
Analysis
Heron Therapeutics (HRTX) Tax Rate (2014 - 2015) Analysis & Trends
Heron Therapeutics (HRTX) has reported Tax Rate for 2 consecutive years, with 363.99% the latest figure, recorded in Q4 2015.
- For the quarter ending Q4 2015, Tax Rate fell 36338.0% year-over-year to 363.99%; the trailing twelve-month figure through Dec 2015 stood at 116.38% (down 11622.0% YoY), and the FY2015 full-year result was 116.38%, down 15080.0% from the prior year.
- Tax Rate fell to 363.99% in Q4 2015 per HRTX's latest filing, from 0.61% in the prior quarter.
- Across five years, Tax Rate topped out at 0.61% in Q4 2014 and bottomed at 363.99% in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 26.36% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -16.71% |
| 10 | Heron Therapeutics | 64.55 Mn | 21.89 Mn | 26.09 Mn | - |